These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 15255456

  • 1. Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study.
    Dogan A, Ergene O, Nazli C, Kinay O, Altinbas A, Ucarci Y, Ergene U, Ozaydin M, Gedikli O.
    Acta Cardiol; 2004 Jun; 59(3):255-61. PubMed ID: 15255456
    [Abstract] [Full Text] [Related]

  • 2. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
    Bellandi F, Simonetti I, Leoncini M, Frascarelli F, Giovannini T, Maioli M, Dabizzi RP.
    Am J Cardiol; 2001 Sep 15; 88(6):640-5. PubMed ID: 11564387
    [Abstract] [Full Text] [Related]

  • 3. Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators.
    Stroobandt R, Stiels B, Hoebrechts R.
    Am J Cardiol; 1997 Feb 15; 79(4):418-23. PubMed ID: 9052343
    [Abstract] [Full Text] [Related]

  • 4. Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group.
    Crijns HJ, Gosselink AT, Lie KI.
    Cardiovasc Drugs Ther; 1996 May 15; 10(2):145-52. PubMed ID: 8842506
    [Abstract] [Full Text] [Related]

  • 5. A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation.
    Kochiadakis GE, Igoumenidis NE, Hamilos ME, Marketou ME, Chlouverakis GI, Vardas PE.
    Am J Cardiol; 2007 Jun 15; 99(12):1721-5. PubMed ID: 17560882
    [Abstract] [Full Text] [Related]

  • 6. Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses.
    Kochiadakis GE, Igoumenidis NE, Hamilos MI, Tzerakis PG, Klapsinos NC, Zacharis EA, Vardas PE.
    Chest; 2004 Feb 15; 125(2):377-83. PubMed ID: 14769712
    [Abstract] [Full Text] [Related]

  • 7. Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial.
    Boriani G, Biffi M, Capucci A, Botto GL, Broffoni T, Rubino I, Della Casa S, Sanguinetti M, Magnani B.
    Ann Intern Med; 1997 Apr 15; 126(8):621-5. PubMed ID: 9103129
    [Abstract] [Full Text] [Related]

  • 8. Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study.
    Capucci A, Villani GQ, Aschieri D, Piepoli M.
    Int J Cardiol; 1999 Feb 28; 68(2):187-96. PubMed ID: 10189007
    [Abstract] [Full Text] [Related]

  • 9. Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm?
    Kochiadakis GE, Marketou ME, Igoumenidis NE, Chrysostomakis SI, Mavrakis HE, Kaleboubas MD, Vardas PE.
    Pacing Clin Electrophysiol; 2000 Nov 28; 23(11 Pt 2):1883-7. PubMed ID: 11139949
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of dronedarone versus propafenone in the maintenance of sinus rhythm in patients with atrial fibrillation after electrical cardioversion.
    Chun KJ, Byeon K, Im SI, Park KM, Park SJ, Kim JS, On YK.
    Clin Ther; 2014 Sep 01; 36(9):1169-75. PubMed ID: 25134972
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Kosior DA, Kochanowski J, Scisło P, Piatkowski R, Postuła M, Rabczenko D, Opolski G.
    Cardiol J; 2009 Sep 01; 16(6):521-7. PubMed ID: 19950088
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs.
    Balla I, Petrela E, Kondili A.
    Anadolu Kardiyol Derg; 2011 Nov 01; 11(7):600-6. PubMed ID: 21911317
    [Abstract] [Full Text] [Related]

  • 13. Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study.
    Bellandi F, Dabizzi RP, Cantini F, Natale MD, Niccoli L.
    Cardiovasc Drugs Ther; 1996 May 01; 10(2):153-7. PubMed ID: 8842507
    [Abstract] [Full Text] [Related]

  • 14. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.
    Bianconi L, Mennuni M, Lukic V, Castro A, Chieffi M, Santini M.
    J Am Coll Cardiol; 1996 Sep 01; 28(3):700-6. PubMed ID: 8772759
    [Abstract] [Full Text] [Related]

  • 15. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C, Longas-Tejero MA, Bergmann JF, Belmin J.
    Cochrane Database Syst Rev; 2012 May 16; (5):CD005049. PubMed ID: 22592700
    [Abstract] [Full Text] [Related]

  • 16. Oral loading with propafenone: a placebo-controlled study in elderly and nonelderly patients with recent onset atrial fibrillation.
    Boriani G, Biffi M, Capucci A, Botto GL, Broffoni T, Rubino I, Della Casa S, Sanguinetti M, Branzi A, Magnani B.
    Pacing Clin Electrophysiol; 1998 Nov 16; 21(11 Pt 2):2465-9. PubMed ID: 9825368
    [Abstract] [Full Text] [Related]

  • 17. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA, Kalogeropoulos A, Patsouras N, Manolis AS.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):859-63. PubMed ID: 15312872
    [Abstract] [Full Text] [Related]

  • 18. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Bergmann JF.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD005049. PubMed ID: 17943835
    [Abstract] [Full Text] [Related]

  • 19. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.
    Fresco C, Proclemer A, Pavan A, Buia G, Vicentini A, Pavan D, Morgera T.
    Clin Cardiol; 1996 May 17; 19(5):409-12. PubMed ID: 8723601
    [Abstract] [Full Text] [Related]

  • 20. Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols.
    Boriani G, Biffi M, Capucci A, Botto G, Broffoni T, Ongari M, Trisolino G, Rubino I, Sanguinetti M, Branzi A, Magnani B.
    Pacing Clin Electrophysiol; 1998 Nov 17; 21(11 Pt 2):2470-4. PubMed ID: 9825369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.